Recurrent gene rearrangements in NOTCH1 and NOTCH2, inducing NOTCH pathway activation, have also been identified in human estrogen receptor (ER)-negative and triple-negative breast cancer samples and cell lines [19]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.